The options paper suggested a capped special funding program separate from the PBS or a legislative change to enable conditional listings on the PBS. The special funding program would be more straightforward and timely. …
A simple, timely option for a 'bridging fund' that can fit within the existing legal framework
July 10, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
BLS and Trexapharm move to bring TREXAVIVE to Australian patients
July 22, 2026 - - BioPharma -
Radiopharm Theranostics reports positive results in tumour trials
July 22, 2026 - - Australian Biotech -
Proteomics International and Healius team up to take Promarker tests national
July 22, 2026 - - Australian Biotech -
Australian approval for AstraZeneca's near‑zero global warming propellant inhaler
July 22, 2026 - - Latest News -
Telix posts strong quarter as revenue nears billion dollar annual run rate
July 21, 2026 - - Australian Biotech -
If this is an example of a bully playing hardball, it's not the companies
July 21, 2026 - - Latest News -
'Our access. Our medicines. Our vaccines. Our medical technology'
July 21, 2026 - - Latest News